Cardioangiologisches Centrum Bethanien

Frankfurt 60431

1 studies enrolling now · 10 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Elevated Lp(a), PE - Pulmonary Embolism, PE - Pulmonary Thromboembolism, Peripheral Arterial Disease, Persistent Atrial Fibrillation, Renal Insufficiency, Stroke

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Running, not enrolling
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation — Completed
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• Cryo Global Registry — Completed
• The DETOUR 2 Clinical Trial — Completed
• Posterior Wall And Left Atrial Appendage Empiric Electrical Isolation for Non-Paroxysmal Atrial Fibrillation — Stopped early
• Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration — Completed